What would you offer as adjuvant therapy for a resected stage IIIB adeno NSCLC in a patient who refuses chemotherapy?  

Can adjuvant durvalumab or other I/O or osimertinib (if EGFR+) be considered?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Stony Brook University Hospital
Thank you so much for the input. 
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Intermountain Healthcare
Curious about your observation that paclitaxel/gem...
Sign in or Register to read more